LON:LABS Life Science REIT (LABS) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartEarnings About Life Science REIT Stock (LON:LABS) Get Life Science REIT alerts:Sign Up Key Stats Today's Range N/A50-Day Range 43.10▼ 43.1052-Week Range N/AVolumeN/AAverage Volume3.84 million shsMarket Capitalization£150.85 millionP/E RatioN/ADividend Yield5.67%Price TargetN/AConsensus RatingN/A Company Overview Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange. The registered office of the Company is located at 6th Floor, 65 Gresham Street, London, EC2V 7NQ. Read More Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABS Stock News HeadlinesLife Science REIT Appoints New Senior Independent DirectorDecember 3, 2025 | tipranks.comSee More Headlines LABS Stock Analysis - Frequently Asked Questions How were Life Science REIT's earnings last quarter? Life Science REIT plc (LON:LABS) issued its earnings results on Tuesday, September, 23rd. The company reported ($8.50) EPS for the quarter. Life Science REIT had a negative trailing twelve-month return on equity of 5.11% and a negative net margin of 68.83%. How do I buy shares of Life Science REIT? Shares of LABS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings9/23/2025Today9/05/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorReal Estate Industry Healthcare REITs Sub-IndustryHealthcare REITs Current SymbolLON:LABS CIKN/A Webwww.lifesciencereit.co.uk Phone44-20-7945-9566FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (8.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£40.62 million Net Margins-68.83% Pretax MarginN/A Return on Equity-5.11% Return on Assets1.25% Debt Debt-to-Equity Ratio46.52 Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales-£22.01 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 76.35 per share Price / BookN/AMiscellaneous Outstanding Shares350,000,000Free FloatN/AMarket Cap£150.85 million OptionableNot Optionable Beta0.08 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (LON:LABS) was last updated on 9/6/2026 by MarketBeat.com Staff. From Our PartnersThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe trapdoor has a date on itRepublicans hold the House 220 to 215. Just three seats could flip control, and more than 35 GOP members have ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Life Science REIT plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Life Science REIT With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
